Evaluating the Cost-Utility of Intestinal Resection Before Anti-Tumor Necrosis Factor Therapy for Strictures in Crohn's Disease in China

被引：0
|
作者：
Tang, X. [1 ]
Bai, X. [1 ]
Yang, H. [1 ]
Han, W. [2 ]
机构：
[1] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Dept Epidemiol & Biostat, Inst Basic Med Sci, School Basic Med,Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1368
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1194
引用
收藏
页码：i2169 / i2169
页数：1
相关论文
共 50 条
  • [21] Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease
    Singh, Siddharth
    Pardi, Darrell S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 457 - +
  • [22] Do Not Assume Symptoms Indicate Failure of Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Bruining, David H.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 395 - 399
  • [23] The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease
    Dotlacil, Vojtech
    Bronsky, Jiri
    Hradsky, Ondrej
    Frybova, Barbora
    Coufal, Stepan
    Skaba, Richard
    Rygl, Michal
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2020, 30 (01) : 27 - 32
  • [24] Successful Treatment of Pleural Tuberculosis While on Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Sonnier, William
    Berry, Travis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2165 - S2166
  • [25] Increases in Sex Hormones during Anti-Tumor Necrosis Factor a Therapy in Adolescents with Crohn's Disease
    DeBoer, Mark D.
    Thayu, Meena
    Griffin, Lindsay M.
    Baldassano, Robert N.
    Denson, Lee A.
    Zemel, Babette S.
    Denburg, Michelle R.
    Agard, Hannah E.
    Herskovitz, Rita
    Long, Jin
    Leonard, Mary B.
    JOURNAL OF PEDIATRICS, 2016, 171 : 146 - +
  • [26] Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type
    Nagata, Yutaka
    Esaki, Motohiro
    Moriyama, Tomohiko
    Hirano, Atsushi
    Umeno, Junji
    Maehata, Yuji
    Torisu, Takehiro
    Matsumoto, Takayuki
    Kitazono, Takanari
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 330 - 338
  • [27] Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn’s disease of inflammatory type
    Yutaka Nagata
    Motohiro Esaki
    Tomohiko Moriyama
    Atsushi Hirano
    Junji Umeno
    Yuji Maehata
    Takehiro Torisu
    Takayuki Matsumoto
    Takanari Kitazono
    Journal of Gastroenterology, 2019, 54 : 330 - 338
  • [28] Efficacy and tolerability of anti-tumor necrosis factor alpha therapy in refractory intestinal Behcet's disease
    Chang, J. Y.
    Jung, P. Soo
    Jun, P. Jae
    Il, K. Tae
    Hee, C. Jae
    Jihye, P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1665 - i1666
  • [29] Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab
    Korzenik, JR
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 285 - +
  • [30] Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies
    Di Sabatino, Antonio
    Pender, Sylvia L. F.
    Jackson, Claire L.
    Prothero, Joanna D.
    Gordon, John N.
    Picariello, Lucia
    Rovedatti, Laura
    Docena, Guillermo
    Monteleone, Giovanni
    Rampton, David S.
    Tonelli, Francesco
    Corazza, Gino R.
    Macdonald, Thomas T.
    GASTROENTEROLOGY, 2007, 133 (01) : 137 - 149
12345